{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:22:05Z","timestamp":1788171725852,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.clindermatol.2003.11.009","type":"journal-article","created":{"date-parts":[[2004,1,28]],"date-time":"2004-01-28T17:47:27Z","timestamp":1075312047000},"page":"481-484","source":"Crossref","is-referenced-by-count":10,"title":["Commercial preparations and handling of botulinum toxin type A and type B"],"prefix":"10.1016","volume":"21","author":[{"given":"Jennifer L","family":"Parish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.11.009_BIB1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0041-0101(02)00086-7","article-title":"Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety","volume":"40","author":"Aoki","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/sder.2001.24421","article-title":"Botulinum toxin type B","volume":"20","author":"Callaway","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1524-4725.2003.29017.x","article-title":"Comparison of botulinum toxin types A and B","volume":"29","author":"Matarasso","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S1076-0512(98)00178-2","article-title":"Dilution and storage of botulinum toxin","volume":"24","author":"Klein","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.48.1.249","article-title":"Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use","volume":"48","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.138.4.510","article-title":"Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative","volume":"138","author":"Alam","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4065\/75.7.701","article-title":"Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections","volume":"75","author":"Gassner","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB9","unstructured":"Package insert on Botox\u00ae Cosmetic (botulinum toxin type A) purified neurotoxin complex. Irvine, CA: Allergan Inc.; 2002"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB10","unstructured":"Package insert on Myobloc. San Diego, CA: Elan Pharmaceuticals; 2000"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhn.2002.124706","article-title":"Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines","volume":"126","author":"Ramirez","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0733-8635(02)00043-8","article-title":"Update on botulinum toxin for facial aesthetics","volume":"20","author":"Cather","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1524-4725.2002.02037.x","article-title":"Botulinum toxin type B for glabellar wrinkles","volume":"28","author":"Sadick","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mjd.2000.105567","article-title":"Pharmacology of botulinum toxin","volume":"43","author":"Huang","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB15","unstructured":"Package insert on Dysport. Berkshire, U.K.: Ipsen Ltd.; 2001"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"Nussgens","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/sder.2001.25138","article-title":"Botulinum toxin type A","volume":"20","author":"Carruthers","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB20","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00006534-200203000-00066","article-title":"Botulinum toxin","volume":"109","author":"Matarasso","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB21","first-page":"S22","article-title":"The biochemistry of botulinum toxin type B","volume":"55","author":"Setler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-4362.1999.00722.x","article-title":"The cosmetic uses of botulinum toxin type A","volume":"38","author":"Benedetto","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S1076-0512(98)00184-8","article-title":"Botulinum toxin","volume":"24","author":"Fulton","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1067\/mjd.2002.119202","article-title":"Surgical pearl","volume":"46","author":"Flynn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.285.6.724-b","article-title":"From the Food and Drug Administration","volume":"285","author":"Schwetz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB26","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1097\/00006534-200205000-00061","article-title":"Preliminary experience with botulinum toxin type B in hyperkinetic facial lines","volume":"109","author":"Ramirez","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/019459989310800205","article-title":"Crystalline preparation of botulinum toxin type A (Botox)","volume":"108","author":"Gartlan","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2003.11.009_BIB28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1076-0512(95)00464-5","article-title":"Cosmetic denervation of the muscles of facial expression with botulinum toxin","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T10:50:03Z","timestamp":1550227803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0738081X03001111"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.11.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}